|
|
|
|
HLA Symposium - in health and disease, 28th and 29th of June 2022, Zurich, Switzerland
Thank you for your participation! It was a great pleasure to welcome you in here in Zurich and we have enjoyed the fantastic event a lot!
We are pleased to announce our international symposium on the topic HLA - in health and disease, which will take place on June 28-29, 2022 at the University Hospital Zurich. We will bring together internationally renowned experts and young scientists from this highly interesting field of research. The aim is to exchange current research results on the topic, learn from outstanding scientists and initiate new collaborations. And we want to invite you to be part of it. Please find below further information. Registration is mandatory, but free of charge. Places are limited.
Organizers:
Roland Martin - Neuroimmunology and MS Research, Dep. of Neurology, University Hospital Zurich/ University of Zurich, Switzerland
Hans-Georg Rammensee - Department of Immunology, Institute of Cell Biology, University of Tübingen, Germany &
Karolin Léger - Scientific Coordinator, Dep. of Neurology, University of Zurich, Switzerland
We are pleased to announce our international symposium on the topic HLA - in health and disease, which will take place on June 28-29, 2022 at the University Hospital Zurich. We will bring together internationally renowned experts and young scientists from this highly interesting field of research. The aim is to exchange current research results on the topic, learn from outstanding scientists and initiate new collaborations. And we want to invite you to be part of it. Please find below further information. Registration is mandatory, but free of charge. Places are limited.
Organizers:
Roland Martin - Neuroimmunology and MS Research, Dep. of Neurology, University Hospital Zurich/ University of Zurich, Switzerland
Hans-Georg Rammensee - Department of Immunology, Institute of Cell Biology, University of Tübingen, Germany &
Karolin Léger - Scientific Coordinator, Dep. of Neurology, University of Zurich, Switzerland
Confirmed speaker (alphabetical order)
Sebastian Amigorena - Centre de Recherche, INSERM U932, Institut Curie, Paris, France
Michael Birnbaum - Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Boston, USA
Søren Buus - Dept. of Immunology and Microbiology, University of Copenhagen, Denmark
Mary Carrington - Laboratory of Integrative Cancer Immunology, Center for Cancer Research, NIH, Frederick, USA
Lars Fugger - Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK
Steven Marsh - Anthony Nolan Research Institute & UCL Cancer Institute, London, UK
Frank Momburg - Translational Immunology, German Cancer Research Center, Heidelberg, Germany
Antonio Lanzavecchia - Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland
Sophie Limou - Center for Research in Transplantation and Translational Immunology, University of Nantes, France
Tomas Olsson - Department of Neurology, Karolinska Institutet, Department of Clinical Neuroscience, Stockholm, Sweden
Jamie Rossjohn - Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia
Olaf Rötzschke - Singapur Immunology Network, Singapur
Pere Santamaria - Department of Microbiology, Immunology & Infectious Diseases, University of Calgary, Canada
Alessandro Sette - Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, USA
Craig Slingluff - University of Virginia School of Medicine, Charlottesville, VA, USA
Ludvig Sollid - Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, Oslo, Norway
Mireia Sospedra - Neuroimmunology and MS Research, Dep. of Neurology, University of Zurich, Switzerland
Program
Booklet (a hard copy will be distributed on site)
Michael Birnbaum - Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Boston, USA
Søren Buus - Dept. of Immunology and Microbiology, University of Copenhagen, Denmark
Mary Carrington - Laboratory of Integrative Cancer Immunology, Center for Cancer Research, NIH, Frederick, USA
Lars Fugger - Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK
Steven Marsh - Anthony Nolan Research Institute & UCL Cancer Institute, London, UK
Frank Momburg - Translational Immunology, German Cancer Research Center, Heidelberg, Germany
Antonio Lanzavecchia - Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland
Sophie Limou - Center for Research in Transplantation and Translational Immunology, University of Nantes, France
Tomas Olsson - Department of Neurology, Karolinska Institutet, Department of Clinical Neuroscience, Stockholm, Sweden
Jamie Rossjohn - Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia
Olaf Rötzschke - Singapur Immunology Network, Singapur
Pere Santamaria - Department of Microbiology, Immunology & Infectious Diseases, University of Calgary, Canada
Alessandro Sette - Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, USA
Craig Slingluff - University of Virginia School of Medicine, Charlottesville, VA, USA
Ludvig Sollid - Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, Oslo, Norway
Mireia Sospedra - Neuroimmunology and MS Research, Dep. of Neurology, University of Zurich, Switzerland
Program
Booklet (a hard copy will be distributed on site)
|
Venue
The HLA Symposium will take place at the lecture hall NORD 1, which is located at the center of the University Hospital Zürich (Frauenklinikstrasse 26, 8091 Zürich) Please use tram number 6, 9 and 10 to station "ETH/Universitätsspital" and follow the yellow way as indicated. The entrance is signposted and the lecture hall is at the top floor, D. There are a few public parking slots available, but public transport is recommended. |
|
Contact: hlasymposium@nims-zh.ch
Kindly supported by
|
|
|
|
|
|
|
|
